Christine J. Weegink

Statistics

Publications

Citations

H-Index

Active since

1993

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

University of Amsterdam

GGD Amsterdam

Erasmus MC

Vertex Pharmaceuticals (United States)

Christine J. Weegink is an author at Amsterdam UMC Location University of Amsterdam specializing in viral hepatitis, infectious diseases, and antiviral therapy.

Publications per year

1993–2013

Publications

Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir

Christoph Sarrazin, Tara L. Kieffer, Doug J. Bartels et al. · Gastroenterology · 2007 · 614 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study

Hendrik W. Reesink, Stefan Zeuzem, Christine J. Weegink et al. · Gastroenterology · 2006 · 396 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

Geoffrey Dusheiko, Janice Main, H. C. Thomas et al. · Journal of Hepatology · 1996 · 352 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +15

Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C

Nicole Forestier, Hendrik W. Reesink, Christine J. Weegink et al. · Hepatology · 2007 · 253 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Sexual transmission of hepatitis C virus

Dorine Bresters, H. W. Reesink, C.L. van der Poel et al. · The Lancet · 1993 · 231 citations

Veterinary Medicine, Infectious Diseases, Microbiology +14

1–5 of 34